FDA Adverse Event Death Summary report: N

QDOT-MICRO, BI-DIRECTIONAL, D-F CURVE, C3, SPLIT HANDLE

MDR report key: 18599345 · Received January 29, 2024

Report

Report Number
2029046-2024-00322
Event Type
Death
Date Received
January 29, 2024
Date of Event
January 5, 2024
Report Date
February 21, 2024
Manufacturer
BIOSENSE WEBSTER INC
Product Code
DRF
UDI-DI
10846835016758
PMA / PMN Number
P210027
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

ON 31-JAN-2024, BWI RECEIVED ADDITIONAL INFORMATION INDICATING THAT THE PREVIOUSLY REPORTED EVENT DATE OF 8-JAN-2024 IS ACTUALLY 5-JAN-2024. IF ADDITIONAL INFORMATION IS RECEIVED REGARDING THIS EVENT, A SUPPLEMENTAL 3500A REPORT WILL BE SUBMITTED TO THE FDA. MANUFACTURER'S REFERENCE NUMBER: (B)(4).

Additional Manufacturer Narrative · 0

SINCE NO DEVICE HAS BEEN RECEIVED FOR ANALYSIS, NO PRODUCT INVESTIGATION CAN BE PERFORMED, AND THE CUSTOMER COMPLAINT CANNOT BE CONFIRMED. MANUFACTURER RECORD EVALUATION CANNOT BE CONDUCTED BECAUSE THE NO LOT NUMBER WAS PROVIDED BY THE CUSTOMER. THIS REPORT IS BEING SUBMITTED PURSUANT TO THE PROVISIONS OF 21 CFR, PART 803. THIS REPORT MAY BE BASED ON INFORMATION WHICH HAS NOT BEEN INVESTIGATED OR VERIFIED PRIOR TO THE REQUIRED REPORTING DATE. THIS REPORT DOES NOT REFLECT A CONCLUSION BY BIOSENSE WEBSTER, INC., OR ITS EMPLOYEES THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE PRODUCT, BIOSENSE WEBSTER, INC. OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE POTENTIAL EVENT DESCRIBED IN THIS REPORT. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL REPORT, A FOLLOW-UP REPORT WILL BE FILED AS APPROPRIATE. IF ADDITIONAL INFORMATION IS RECEIVED REGARDING THIS EVENT, A SUPPLEMENTAL 3500A REPORT WILL BE SUBMITTED TO THE FDA. MANUFACTURER'S REFERENCE NUMBER: (B)(4) BIOSENSE WEBSTER MANUFACTURER'S REFERENCE NUMBER (B)(4) HAS 2 REPORTS.

Description of Event or Problem · 0

IT WAS REPORTED THAT A PATIENT UNDERWENT AN ATRIAL FIBRILLATION ABLATION WITH A NGEN GENERATOR AND A QDOT-MICRO, BI-DIRECTIONAL, D-F CURVE, C3, SPLIT HANDLE AND THE PATIENT EXPERIENCED POST-OP ESOPHAGEAL FISTULA THAT RESULTED IN DEATH. THE COMPLICATION WAS DECLARED SEVERAL DAYS/WEEKS AFTER THE INTERVENTION. THE PHYSICIAN'S OPINION WAS THAT USE OF THE QDOT-MICRO CONTRIBUTED TO THE DEATH BUT DID NOT ELABORATE ON THE ISSUE. THE GENERATOR WAS IN TEMPERATURE CONTROL MODE WITH A TEMPERATURE CUT OFF OF 55°C. THE CORRECT CATHETER SETTINGS WERE SELECTED ON THE GENERATOR. NO ERROR MESSAGES OBSERVED ON BIOSENSE WEBSTER EQUIPMENT DURING THE PROCEDURE. WHEN ASKED WHAT MODALITIES WERE USED TO PREVENT ESOPHAGEAL INJURY, THE PHYSICIAN RESPONDED WITH: "TEMPERATURE IN THE ESOPHAGUS". THE PHYSICIAN ALSO STATED THAT NO PERFORATIONS OCCURRED DURING THE PROCEDURE. THIS REPORT IS FOR THE QDOT CATHETER. ANOTHER REPORT HAS BEEN SUBMITTED FOR THE NGEN RF GENERATOR

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2537706 QDOT-MICRO, BI-DIRECTIONAL, D-F CURVE, C3, SPLIT HANDLE CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION DRF BIOSENSE WEBSTER INC 10846835016758

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Death| L CARTO 3 SYSTEM WITH VISITAG.| NGEN PUMP, EU CONFIGURATION.